Thalidomide-induced neuropathy.
Crawford
C L
CL
D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy*; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D013792:Thalidomide / Q000009:adverse effects* / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D013792:Thalidomide